BriaCell Therapeutics BCTX
NASDAQ BCTX
$4.04 -0.07 (-1.70%)
At close: Oct 2, 2026 · 4:00 PM EDT

BriaCell Therapeutics (BCTX) Other Accumulated Expenses (2021)

Updated

BriaCell Therapeutics (BCTX) posted Other Accumulated Expenses of $80,967 for fiscal Q4 2021 (quarter ended Jul 31, 2021).

Analysis

BriaCell Therapeutics (BCTX) Other Accumulated Expenses (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 BriaCell Therapeutics 29.80 Mn 29.15 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2021 80,967.00
API Access

BriaCell Therapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=BCTX&period=max&api_key=YOUR_API_KEY